Screening for Barrett’s Esophagus and Esophageal Adenocarcinoma: Rationale, Recent Progress, Challenges, and Future Directions  Sarmed S. Sami, Krish.

Slides:



Advertisements
Similar presentations
Risk of Esophageal Adenocarcinoma and Mortality in Patients With Barrett's Esophagus: A Systematic Review and Meta-analysis  Marjolein Sikkema, Pieter.
Advertisements

Esophageal Adenocarcinoma
From: Upper Endoscopy for Gastroesophageal Reflux Disease: Best Practice Advice From the Clinical Guidelines Committee of the American College of Physicians.
Abnormal Liver Tests and Fatty Liver on Ultrasound
Thrombocytopenia With Abnormal Liver Function Tests
Ruben Hernaez, MD, MPH, PhD  Clinical Gastroenterology and Hepatology 
Survival of Patients With Superficial Esophageal Adenocarcinoma After Endoscopic Treatment vs Surgery  Saowanee Ngamruengphong, Herbert C. Wolfsen, Michael.
Aaron P. Thrift, Thomas L. Vaughan, Lesley A. Anderson, David C
Prevention, Early Detection, and Overdiagnosis of Colorectal Cancer Within 10 Years of Screening Colonoscopy in Germany  Hermann Brenner, Lutz Altenhofen,
Katsunori Matsueda, Tatsuya Toyokawa 
When Should We Suspect Hereditary Colorectal Cancer Syndrome?
Right Upper Quadrant Pain and a Normal Abdominal Ultrasound
Cause-Specific Mortality of People With Barrett's Esophagus Compared With the General Population: A Population-Based Cohort Study  Masoud Solaymani–Dodaran,
Benjamin C.Y. Wong, Yoshikazu Kinoshita 
Maged K. Rizk, James Merlino, Ashish Atreja 
A Model to Determine Absolute Risk for Esophageal Adenocarcinoma
Amit G. Singal, Jasmin A. Tiro, Samir Gupta 
Risk of Colorectal Cancer in Patients With Ulcerative Colitis: A Meta-analysis of Population-Based Cohort Studies  Tine Jess, Christine Rungoe, Laurent.
Serhat Bor, Gul Kitapcioglu, Peter Dettmar, Tim Baxter 
Short-Bowel Syndrome Clinical Gastroenterology and Hepatology
Volume 155, Issue 4, Pages (October 2018)
Amnon Sonnenberg, MD, MSc, Brent Y. Lee, MD 
Seth D. Crockett, A. Sidney Barritt, Nicholas J. Shaheen 
Volume 150, Issue 4, Pages (April 2016)
Radiofrequency Ablation of Barrett's Esophagus Reduces Esophageal Adenocarcinoma Incidence and Mortality in a Comparative Modeling Analysis  Sonja Kroep,
Should the Reflex Be Reflux
Personalizing Colorectal Cancer Screening: A Systematic Review of Models to Predict Risk of Colorectal Neoplasia  Gene K. Ma, Uri Ladabaum  Clinical Gastroenterology.
Sibu Varghese, Pierre Lao–Sirieix, Rebecca C. Fitzgerald 
Metastatic Breast Cancer Presenting as Esophageal Stricture
Esophageal Adenocarcinoma 10 Years After Surgical Resection of Barrett’s Esophagus: Unusual Presentation as Subepithelial Tumor  Andreas Probst, Tina.
Predicted Increases in Incidence of Colorectal Cancer in Developed and Developing Regions, in Association With Ageing Populations  Kelvin K.F. Tsoi, Hoyee.
A Multibiomarker Risk Score Helps Predict Risk for Barrett’s Esophagus
Risk of Esophageal Adenocarcinoma and Mortality in Patients With Barrett's Esophagus: A Systematic Review and Meta-analysis  Marjolein Sikkema, Pieter.
Endoscopic Therapy for Barrett's Esophagus
Aaron P. Thrift, PhD  Clinical Gastroenterology and Hepatology 
When Should Screening Stop for Elderly Individuals at Average and Increased Risk for Colorectal Cancer?  Folasade P. May, Samir Gupta  Clinical Gastroenterology.
Abnormal Liver Tests and Fatty Liver on Ultrasound
New Models of Gastroenterology Practice
Relationship Between Detection of Adenomas by Flexible Sigmoidoscopy and Interval Distal Colorectal Cancer  Shari S. Rogal, Paul F. Pinsky, Robert E.
Stephen J. Rulyak, David A. Lieberman, Edward H. Wagner, Margaret T
Jianguang Ji, Kari Hemminki  Clinical Gastroenterology and Hepatology 
Coffee and Colorectal Cancer: Grounds for Prevention?
Issue Highlights Clinical Gastroenterology and Hepatology
Swati G. Patel, Dennis J. Ahnen 
Amnon Sonnenberg  Clinical Gastroenterology and Hepatology 
Factors Associated With Progression of Barrett’s Esophagus: A Systematic Review and Meta-analysis  Rajesh Krishnamoorthi, Siddharth Singh, Karthik Ragunathan,
Incidence of Progression of Persistent Nondysplastic Barrett’s Esophagus to Malignancy  Yonne Peters, Judith Honing, Wietske Kievit, Christine Kestens,
Deborah A. Fisher, Joseph Galanko, Tara K. Dudley, Nicholas J. Shaheen 
Colorectal Cancer Screening: How to Stop a Moving Target
Heiko Pohl, Douglas J. Robertson 
Gender as a Risk Factor for Advanced Neoplasia and Colorectal Cancer: A Systematic Review and Meta-analysis  Stephen P. Nguyen, Stephen Bent, Yea-Hung.
Volume 149, Issue 3, Pages e4 (September 2015)
Epidemiology, Mechanisms, and Management of Diabetic Gastroparesis
Thrombocytopenia With Abnormal Liver Function Tests
Issue Highlights Clinical Gastroenterology and Hepatology
Cost Utility of Screening for Barrett’s Esophagus With Esophageal Capsule Endoscopy Versus Conventional Upper Endoscopy  Joel H. Rubenstein, John M. Inadomi,
Screening and Surveillance Colonoscopy in Chronic Crohn's Colitis: Results of a Surveillance Program Spanning 25 Years  Sonia Friedman, Peter H. Rubin,
Hepatitis C Virus Infection, Age, and Hispanic Ethnicity Increase Mortality From Liver Cancer in the United States  Zobair M. Younossi, Maria Stepanova 
Rocco Ricciardi, Robert D. Madoff, David A. Rothenberger, Nancy N
A 27-Year-Old Woman With Constipation: Diagnosis and Treatment
Familial Colorectal Cancer, Beyond Lynch Syndrome
Lauren B. Gerson, Peter J. Kahrilas, Ronnie Fass 
Volume 138, Issue 6, Pages (May 2010)
David S. Fefferman, Richard J. Farrell 
Acceptability, Accuracy, and Safety of Disposable Transnasal Capsule Endoscopy for Barrett's Esophagus Screening  Sarmed S. Sami, Prasad G. Iyer, Prachi.
Prateek Sharma, Gary W. Falk, Allan P
Clinical Gastroenterology and Hepatology
Medical Therapy for Refractory Pediatric Crohn’s Disease
Challenges of NIH Funding for Young Investigators: How the AGA Is Filling the Gap via the AGA Research Foundation  Timothy C. Wang, Rhonda F. Souza  Clinical.
Persistence of Nondysplastic Barrett’s Esophagus Is Not Protective Against Progression to Adenocarcinoma  Rajesh Krishnamoorthi, Guilherme Piovezani Ramos,
Presentation transcript:

Screening for Barrett’s Esophagus and Esophageal Adenocarcinoma: Rationale, Recent Progress, Challenges, and Future Directions  Sarmed S. Sami, Krish Ragunath, Prasad G. Iyer  Clinical Gastroenterology and Hepatology  Volume 13, Issue 4, Pages 623-634 (April 2015) DOI: 10.1016/j.cgh.2014.03.036 Copyright © 2015 AGA Institute Terms and Conditions

Figure 1 Tools currently undergoing evaluation for use in BE screening. (A) Cytosponge (Cambridge University); (B) EG scan system (Intromedic, Ltd, Seoul, South Korea) (disconnected); (C) EG scan system (connected); and (D) EndoSheath system (Vision-Sciences, Inc, Orangeburg, NY). Clinical Gastroenterology and Hepatology 2015 13, 623-634DOI: (10.1016/j.cgh.2014.03.036) Copyright © 2015 AGA Institute Terms and Conditions

Figure 2 (A) Estimated incidence of EAC in populations with weekly GERD symptoms. Incidences of colorectal cancer (CRC) and breast cancer (BrCa) are displayed for context. The benchmark incidence of cancer for endorsed screening is shown by the green horizontal line. Thick lines represent EAC, thin lines represent CRC, and dotted lines represent BrCa. Thin dashed lines represent the upper and lower confidence limits of the incidence of EAC in men with weekly GERD, and the upper confidence limit of EAC in women with weekly GERD. The lower confidence limit for women with GERD overlaps the point estimate incidence of EAC in women and is not visible on the figure. (B) Estimated incidence of EAC in populations with daily GERD symptoms. Reprinted by permission from Macmillan Publishers Ltd: The American Journal of Gastroenterology, copyright 2011.56 Clinical Gastroenterology and Hepatology 2015 13, 623-634DOI: (10.1016/j.cgh.2014.03.036) Copyright © 2015 AGA Institute Terms and Conditions

Figure 3 Proposed future approach to reducing mortality from EAC by using screening and targeted surveillance coupled with endotherapy. LSBE, long-segment BE; M-BERET, Michigan Barrett’s Esophagus pREdiction Tool. Clinical Gastroenterology and Hepatology 2015 13, 623-634DOI: (10.1016/j.cgh.2014.03.036) Copyright © 2015 AGA Institute Terms and Conditions